Search Results
ESMO 2020 Highlights on durability of clinical benefit and biomarkers with AMG510 in NSCLC
ESMO 2020 Highlights on 1st line lorlatinib for ALK+ NSCLC: The CROWN Study
ESMO 2020 Highlights on 1st line durvalumab and tremelimumab for mPDAC: The PA.7 study
ESMO 2020 Gabriela Fernandes talk: Lung cancer diagnostic test needs: perspective from a thoracic
Immunotherapy trial updates in NSCLC from ESMO 2020
ESMO 2020 Highlights on pembrolizumab as 1st line therapy for aUC: The KEYNOTE-361 study
ESMO 2020 Highlights on nivolumab+cabozantinib as 1st line therapy for aRCC: The CheckMate 9ER study
ESMO 2020 Highlights on lenvatinib plus pembrolizumab in advanced solid tumours: LEAP-005
ESMO highlights: 705MO study in GU cancer
ESMO highlights: genitourinary cancers
ESMO Lung Symposium
ESMO 2020 Highlights on neoadjuvant ICI in early TNBC: The IMpassion031 study
